{
    "pmcid": "10268213",
    "qa_pairs": {
        "What method was used to rapidly determine the specificity of selected nanobodies against the SARS-CoV-2 receptor-binding domain?": [
            "On-yeast competitive selection strategy.",
            "In vitro phage display screening.",
            "In vivo mouse model testing.",
            "High-throughput sequencing analysis."
        ],
        "What potential advantage does the human-based nanobody library offer for the development of therapeutics?": [
            "Reduced immunogenicity, enhancing safety and efficacy for human use.",
            "Increased binding affinity to a wider range of viral proteins.",
            "Enhanced ability to cross the blood-brain barrier.",
            "Improved resistance to proteolytic degradation in the bloodstream."
        ],
        "What was the primary goal of developing a fully synthetic nanobody library using an engineered human VH3-23 variable gene segment?": [
            "To reduce immunogenicity compared to camelid-derived nanobodies by mimicking human antibody structures.",
            "To increase the diversity of nanobody structures beyond what is found in natural immune repertoires.",
            "To enhance the thermal stability of nanobodies for better storage and transport.",
            "To create nanobodies that can bind to multiple viral proteins simultaneously."
        ],
        "What was the significance of the bispecific tetra-nanobody immunoglobulins (bsNb4-Ig) developed in the study?": [
            "They allow for biparatopic engagement of the RBD, enhancing neutralization potency.",
            "They enable the simultaneous targeting of the spike protein and nucleocapsid protein.",
            "They provide a mechanism for delivering antiviral drugs directly to infected cells.",
            "They facilitate the recruitment of immune cells to the site of infection."
        ],
        "Which structural techniques were used to determine the structures of selected nanobodies in complex with the SARS-CoV-2 RBD and spike protein?": [
            "X-ray crystallography and cryo-electron microscopy.",
            "Nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry.",
            "Atomic force microscopy and fluorescence resonance energy transfer (FRET).",
            "Single-molecule imaging and electron paramagnetic resonance (EPR)."
        ]
    }
}